| Literature DB >> 35410174 |
Ryo Mizuhara1,2, Shingo Mitaki3, Masahiro Takamura3, Satoshi Abe3, Keiichi Onoda4, Shuhei Yamaguchi5, Atsushi Nagai3.
Abstract
BACKGROUND: Growing evidence suggests that vascular risk factors, especially hypertension, relate not only to cardiovascular disease but also to cognitive impairment. However, the impact of pulse pressure on cognitive function remains controversial. In this study, we evaluated the associations between pulse pressure and cognitive function in a Japanese health examination cohort using propensity matching analysis.Entities:
Keywords: Cognitive functions; Mediation analyses; Propensity-matching; Pulse pressure
Mesh:
Year: 2022 PMID: 35410174 PMCID: PMC8996505 DOI: 10.1186/s12883-022-02666-6
Source DB: PubMed Journal: BMC Neurol ISSN: 1471-2377 Impact factor: 2.474
Baseline characteristics before and after propensity matching
| Characteristics | Before matching | After matching | ||||
|---|---|---|---|---|---|---|
| Pulse pressure (mmHg) | Pulse pressure (mmHg) | |||||
| Lower (< 65) | Higher (≧65) | Lower (< 65) | Higher (≧65) | Balance statistics | ||
| No. of subjects | 2017 | 439 | 433 | 433 | ||
| Age (year) | 59.8 (10.4) | 65.4 (8.5) | < 0.001 | 64.9 (8.6) | 65.4 (8.4) | 0.030 |
| Female (%) | 46.6 | 51.9 | 0.003 | 50.3 | 51.5 | -0.023 |
| Hypertension (%) | 32 | 59.2 | < 0.001 | 60.2 | 58.9 | -0.028 |
| Diabetes (%) | 9 | 14.1 | < 0.001 | 13.4 | 13.6 | 0.007 |
| Hyperlipidemia (%) | 48.3 | 50.8 | 0.087 | 52 | 50.6 | -0.028 |
Physical, brain, and cognitive assessment in participants with lower and higher pulse pressure after matching
| Pulse pressure (mmHg) | |||
|---|---|---|---|
| Lower (< 65) | Higher (≧65) | ||
| Systolic BP (mmHg) | 127.5(14.2) | 149.9(14.1) | < 0.001 |
| Diastolic BP (mmHg) | 73.7(11.4) | 75.9(11.5) | 0.005 |
| PP (mmHg) | 53.9(7.6) | 74.0(7.3) | < 0.001 |
| SBI | 35 (8.1) | 45 (10.4) | 0.282 |
| PVH grade≧3 | 49 (11.3) | 49 (11.3) | 1.000 |
| SWML | 127 (29.3) | 143 (33.0) | 0.217 |
| CMBs | 44 (9.9) | 32 (7.4) | 0.182 |
| Okabe’s test (shortened version of WAIS-R) | 44.3 (7.1) | 42.7 (7.5) | 0.001 |
| Information | 16.2 (2.8) | 15.9 (2.7) | 0.118 |
| Mental control | 11.9 (3.8) | 11.1 (4.1) | 0.001 |
| Digit span | 9.0 (1.4) | 8.8 (1.5) | 0.011 |
| Assoc. learning | 7.1 (3.0) | 7.0 (3.1) | 0.492 |
| Kohs’ test | 97.9 (18.0) | 95.0 (18.1) | 0.010 |
| FAB | 15.8 (1.5) | 15.7 (1.5) | 0.165 |
| SDS | 34.4 (7.9) | 33.8 (7.7) | 0.229 |
| Apathy scale | 10.9 (5.4) | 11.2 (5.7) | 0.453 |
Abbreviation: BP Blood Pressure, SBI Silent Brain Infarction, PVH Periventricular Hyperintensity, SWML Subcortical White Matter Hyperintensity, CMBs Cerebral Microbleeds, WAIS-R Wechsler Adult Intelligence Scale-Revised, Assoc. Learning Association Learning, FAB Frontal Assessment Battery, SDS Self-rating Depression Scale
Values are mean (SD) or n (%). a p-value of paired t-test or McNemar test
Fig. 1Mediation of the relationship between pulse pressure and cognitive function. a Measurement of systolic blood pressure mediation in the relationship between pulse pressure and Okabe’s test score. b Measurement of systolic blood pressure mediation in the relationship between pulse pressure and Kohs’ test score
The relationship between pulse pressure and cognitive function tested by mediation analysis
| 95% Confidence Interval | ||||||
|---|---|---|---|---|---|---|
| Estimate | Std. Error | Z value | Lower | Upper | ||
| Okabe | ||||||
Direct effects (PP → Okabe) | -0.093 | 0.031 | -2.983 | 0.003 | -0.153 | -0.032 |
Indirect effects (PP → SBP → Okabe) | 0.010 | 0.024 | 0.435 | 0.664 | -0.037 | 0.058 |
Total effects (PP → Okabe) | -0.082 | 0.02 | -4.181 | < 0.001 | -0.121 | -0.044 |
| Kohs | ||||||
Direct effects (PP → Kohs) | -0.312 | 0.077 | -4.072 | < 0.001 | -0.462 | -0.162 |
Indirect effects (PP → SBP → Kohs) | 0.109 | 0.059 | 1.839 | 0.066 | -0.007 | 0.226 |
Total effects (PP → Kohs) | -0.203 | 0.049 | -4.172 | < 0.001 | -0.298 | -0.107 |
Abbreviation: PP Pulse Pressure, SBP Systolic Blood Pressure
Multiple linear regression analysis of cognitive function
| Dependent variable | Independent variables | 95% Confidence Interval | |||||
|---|---|---|---|---|---|---|---|
| B | Std. Error | Lower | Upper | VIF | |||
| Okabe | (constant) | 58.506 | 1.427 | < 0.001 | 55.708 | 61.305 | |
| (R2 adjusted = 0.103) | Age | -0.195 | 0.014 | < 0.001 | -0.223 | -0.167 | 1.194 |
| Sex | 0.076 | 0.289 | 0.793 | -0.490 | 0.642 | 1.117 | |
| Hypertension | -0.336 | 0.317 | 0.290 | -0.958 | 0.286 | 1.246 | |
| Diabetes | -0.079 | 0.473 | 0.867 | -1.006 | 0.848 | 1.046 | |
| Hyperlipidemia | -0.014 | 0.275 | 0.960 | -0.554 | 0.526 | 1.021 | |
| Systolic BP | 0.017 | 0.013 | 0.189 | -0.008 | 0.043 | 2.711 | |
| PP | -0.720 | 0.019 | < 0.001 | -0.109 | -0.034 | 2.633 | |
| Kohs | (constant) | 167.590 | 3.262 | < 0.001 | 161.193 | 173.987 | |
| (R2 adjusted = 0.284) | Age | -0.852 | 0.033 | < 0.001 | -0.917 | -0.788 | 1.194 |
| Sex | -4.654 | 0.660 | < 0.001 | -5.948 | -3.360 | 1.117 | |
| Hypertension | -0.402 | 0.725 | 0.579 | -1.824 | 1.019 | 1.246 | |
| Diabetes | -0.560 | 1.081 | 0.604 | -2.679 | 1.558 | 1.046 | |
| Hyperlipidemia | -0.695 | 0.630 | 0.270 | -1.930 | 0.539 | 1.021 | |
| Systolic BP | -0.009 | 0.030 | 0.767 | -0.067 | 0.049 | 2.711 | |
| PP | -0.104 | 0.043 | 0.017 | -0.189 | -0.019 | 2.633 | |
Abbreviation: VIF Variance Inflation Factor